Sensai
Reading the tape…Pulling live market data…Setting the scene…
Sensai
AI Stock Dissection
AI Stock Dissection
ANURAS
Mr. Gopal Puranmal Agrawal · Surat, India
₹1,210.80
▼-0.30%Anuras is riding strong revenue growth but ultra‑high valuation and weak ROE keep the stock under pressure near the lower end of its 52‑week range.
Exchange
NSI
Currency
INR
Day range
₹1,203.00 – ₹1,217.50
52-week range
₹1,045.20 – ₹1,415.00
Sector
Basic Materials
Industry
Specialty Chemicals
AI investment rating
AI analysis68% confidence
Given a P/E of ~78x versus modest 5.8% ROE, the stock appears overvalued; current price sits near the bottom of its 1‑year range, suggesting limited upside unless earnings accelerate sharply.
14.4% below the 1-year high · trend down
Hedge-fund memo
Today
Shares slipped 0.30% to INR 1,210.8, trading near the lower bound of the day’s range.
This week
The stock has been flat to slightly down, reflecting profit‑margin pressure and lack of fresh catalyst.
This month
Over the past month the price has drifted down 2‑3% as investors digest the high valuation versus earnings growth.
Bull thesis
Bear thesis
News & sentiment
Neutral
1 headlines · 1 outlets · 7d
TradingView·1d ago·Revenue breakdown details disclosed
Real press coverage from the last 7 days, scored by AI for tone — click any headline for the source. This is news sentiment, not social: X / Reddit / Telegram scoring needs a paid social provider. Educational only.
Smart money
Named holders aren't published for this listing (common for Indian stocks). The split at left is live.
Financial health
Profitability
Growth
Balance sheet
Financial statements
Earnings intelligence
Beat estimates in 4 of 4 recent quarters (EPS actual vs. consensus).
3.73 vs 3.3
13.03% surprise
4.31 vs 3
43.67% surprise
3.93 vs 3.5
12.29% surprise
Competitive landscape
| Company | Market cap | P/E | ROE | Op. margin | Rev. growth |
|---|---|---|---|---|---|
| ANURAS | 137.85B | 78.52 | 5.76% | 14.88% | 27.50% |
| LXCHEM | 55.58B | 70.11 | 4.08% | 7.09% | 3.60% |
| CLEAN | 77.49B | 33.75 | 15.31% |
Technical intelligence
Volume
RSI (14) · 70 overbought / 30 oversold
MACD (12,26,9) · MACD vs signal
Candlesticks, volume, RSI and MACD from 499sessions of real Yahoo daily data. Moving averages use full history, so they're accurate at the left edge. Support / resistance are the 52-week low / high. Educational — technical signals are not buy or sell calls.
Risk intelligence
Raw material cost surge (e.g., petrochemicals)
Mitigation: Long‑term supply contracts and hedging programs.
Regulatory tightening on hazardous chemicals
Mitigation: Investment in greener product lines.
Business intelligence
Competitive moat
Strong customer lock‑in through custom formulations and long‑term supply contracts creates a modest differentiation advantage.
Supply chain
Upstream (inputs / suppliers)
↓
Downstream (customers / markets)
M&A / strategic moves
Catalyst calendar
Earnings beat with margin expansion
Launch of a new bio‑based specialty polymer line
Thesis builder
Bull case
Sustained double‑digit revenue growth plus a shift to higher‑margin specialty segments could justify a premium valuation.
Base case
Revenue growth will continue at ~20‑25% YoY while margins stay in the 7‑8% range, keeping earnings modest relative to the lofty multiple.
Bear case
Margin compression, high debt‑to‑equity and an inability to improve ROE will keep the stock stuck in a valuation trap.
Time horizon
12‑18 months
Est. CAGR
20‑25% revenue CAGR over the next 3‑5 years
Entry (qual.)
Buy on a pull‑back to below INR 1,150 if EPS guidance improves.
Exit (qual.)
Target INR 1,400 if P/E narrows to 40‑45x on margin expansion.
Overall conviction 68%
Knowledge graph
Executives & sector are live; peers are clickable → their dissection. Institutional holders shown where the exchange publishes them.
Portfolio impact
Enter tickers + weights, then see how ANURAS fits.
Scenario simulator
Simulate a macro shock and see the illustrative impact:
Tailwind for tech & enablers.
Illustrative impact
Medium prob.Directional illustration only — not modelled on this company's actuals. A real simulator needs company financials.
Explain like…
Re-explain ANURAS for a different audience:
Pick a persona to get a tailored explanation.
Sensai publishes educational market commentary, not investment advice. We are not SEBI-registered investment advisers or research analysts, and nothing here is a recommendation to buy, sell, or hold any security.
Live prices, index levels, and other market data are pulled from third-party feeds, may be delayed, and can be inaccurate or unavailable. Do not rely on them for trading decisions.
Investing in equities carries risk, including the loss of principal. Always do your own research and consider consulting a SEBI-registered adviser before making any investment decision.
Hidden risks
Hidden opportunities
Watch next
Maintain position; consider adding on a pull‑back if earnings guidance improves.
Annual income statement, oldest → newest. Live via Yahoo.
3.1 vs 2.8
10.71% surprise
| 30.07% |
| -5.50% |
| CHEMPLASTS | 32.15B | — | -14.64% | 14.09% | 9.10% |
Peers via Yahoo's similarity graph, same-sector first; fundamentals live. Ask the AI copilot below for a qualitative head-to-head.
Support (day/52w low)
₹1,203.00
Resistance (day/52w high)
₹1,217.50
Volume
1,48,720
Trend
down
RSI (14)
19
MACD
bearish
MA cross
golden
50-day MA
₹1,284.99
200-day MA
₹1,265.55
vs 200-DMA
-4.3%
RSI/MACD computed from 6 months of daily closes; moving averages from Yahoo. Options positioning still needs an options feed.